Alpha DNA Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-58,898
Closed -$448K 192
2024
Q3
$448K Buy
+58,898
New +$448K 0.17% 140